BodyTel Scientific to Exhibit at the Kirchheim Diabetes Forum in Wiesbaden, Germany


HENDERSON, Nev., Oct. 31, 2007 (PRIME NEWSWIRE) -- BodyTel Scientific, Inc. (OTCBB:BDYT), a developer of wireless telemedical measuring devices, announced that the company, for the first time, will take part in the Kirchheim Diabetes Forum in Wiesbaden, Germany from November 2-3, 2007.

BodyTel will present its blood glucose monitoring and diabetes management system, GlucoTel, at booth #3. The Kirchheim Forum brings together a wide variety of persons involved in diabetes treatment, including doctors from specialized offices and clinics, as well as diabetes consultants. BodyTel anticipates launching the market introduction of GlucoTel during the 4th quarter of 2007.

"By year's end our wireless blood sugar measuring device, GlucoTel, should obtain CE certification and thereby become available in Germany," says Michael Berrendorf, Sales Director of BodyTel Europe GmbH. "Before patients show their doctors and diabetes consultants this new glucose measuring device, we want to introduce GlucoTel to as many healthcare professionals as possible. The Kirchheim Forum offers a perfect occasion to do so."

The GlucoTel measurement device is a wireless blood glucose meter that electronically captures the blood sugar level and sends it via Bluetooth to the patient's mobile phone. The data is then sent automatically via text message or internet connection to the company's web database 'BodyTel Center' at www.bodytel.com, where it is stored long-term.

The BodyTel Center is of special interest for doctors and diabetes consultants. Following permission by the patient an authorized third party can access the password-protected web portal. Hence, they can view the patient's blood sugar and other body measurements anytime and from anywhere. A weakened state of health can be spotted and treated at an earlier stage.

About BodyTel Scientific

BodyTel Scientific Inc. is a German-American Telehealth company that specializes in telemedical monitoring and management systems for chronic illnesses. The company combines their know-how in telecommunications, internet and medical technology to create new products and services for the changing needs of global health. BodyTel products are designed not only to simplify home monitoring by patients, but also to ease the communication of 'measured body values' to healthcare professionals or other caregivers by bridging the gap between the patient and the caregivers instantaneously. BodyTel's products -- GlucoTel, PressureTel and WeightTel are each at different stages of development and approval processes. Further information can be found at www.bodytel.com or www.chainrelations.de/presse.

Forward-Looking Statements

Statements regarding the Company's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties that could cause actual results to differ materially from the potential results discussed in the forward-looking statements. Forward-looking statements in this press release include that BodyTel anticipates launching the market introduction of GlucoTel during the 4th quarter of 2007, and that By years' end our wireless blood sugar measuring device, GlucoTel, should obtain CE certification and thereby become available in Germany. Actual results may differ materially from those currently anticipated due to a number of factors as we may find that our products must compete with cheaper or better products; we may not be able to retain key employees; a bigger market may not develop for our products and we may not be able to continue to attract new customers; we may face litigation if our technology fails to work when required; our intellectual property may be attacked and defeated in court proceedings; our patent and FDA/CE filings may be rejected by the patent offices and regulators; other companies may discover and develop better or cheaper technologies that would render our products obsolete and we may not have sufficient funding to further develop and/or market our technology. Readers are directed to the BodyTel Scientific, Inc.'s reports as filed with the U.S. Securities and Exchange Commission from time to time, including but not limited to its 8-K filed December 14, 2006 under our prior name Sellcell.net which outlined the company's current business for further information and factors that may affect BodyTel Scientific Inc.'s business and results of operations as well as the Company's form 10-KSB filed on December 15, 2006 and the Company's form 10-QSB filed on January 16, 2007. BodyTel Scientific Inc. undertakes no obligations to publicly update any forward-looking statements to reflect future events or circumstances.



            

Contact Data